The incidence of idiopathic intracranial hypertension (IIH) — characterized by increased cerebral spinal fluid (CSF) pressure — is rising considerably, corresponding to population increases in body ...
For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional ...
GLP-1 receptor agonists (RAs) are associated with fewer headaches and visual symptoms, reduced medication use, and less need for procedures — including bariatric surgery — compared with conventional ...
A new study led by investigators from Mass General Brigham shows that a brain waste- “clean-up” system is influenced by intracranial pressure. The system, called the glymphatic system, was ...
A new study led by investigators from Mass General Brigham shows that a brain waste- "clean-up" system is influenced by intracranial pressure. The system, called the glymphatic system, was ...
Intracranial hypertension (IH), a clinical condition typically seen in the intensive care unit, is caused by increased pressure surrounding the brain. In many situations, the cause of chronic IH is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results